Experience with a Novel Efalizumab‐Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation

Autor:	Turgeon, N.A *, Avila, J.G, Cano, J.A, Hutchinson, J.J, Badell, I.R, Page, A.J, Adams, A.B, Sears, M.H, Bowen, P.H, Kirk, A.D, Pearson, T.C, Larsen, C.P
Zdroj:	In American Journal of Transplantation September 2010 10(9):2082-2091
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Plný text